Jon Warkentin
- Infectious Diseases top 5%
- Tuberculosis Research and Epidemiology 21
- Clostridium difficile and Clostridium perfringens research 2
- Epidemiology top 10%
- Pneumocystis jirovecii pneumonia detection and treatment 10
- Pneumonia and Respiratory Infections 9
- Mycobacterium research and diagnosis 9
-
- Infectious Diseases and Tuberculosis 3
- Diagnosis and treatment of tuberculosis 2
-
- Cancer therapeutics and mechanisms 2
- Co-authors
- Timothy R. SterlingMarie R. GriffinFernanda MaruriAmondrea BlackmanAyumi ShintaniEd MitchelWilliam SchaffnerTimothy F. Jones
- Journals
- The International Journal of Tuberculosis and Lung Disease (4 papers)Journal of Clinical Microbiology (2 papers)Emerging infectious diseases (2 papers)
- Partner nations
- United StatesFijiSouth Africa
In The Last Decade
Jon Warkentin
21 papers receiving 489 citations
Peers
Comparison fields: 5 of 76
- Infectious Diseases 408
- Epidemiology 335
- Molecular Medicine 31
- Surgery 197
- Toxicology 8
Countries citing papers authored by Jon Warkentin
This map shows the geographic impact of Jon Warkentin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Warkentin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Warkentin more than expected).
Fields of papers citing papers by Jon Warkentin
This network shows the impact of papers produced by Jon Warkentin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Warkentin. The network helps show where Jon Warkentin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jon Warkentin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 6 | |
| 3 | 2020 | 3 | |
| 4 | 2020 | 3 | |
| 5 | 2019 | 31 | |
| 6 | 2014 | 2 | |
| 7 | 2014 | 10 | |
| 8 | Impact of a shortage of first-line antituberculosis medication on tuberculosis control - United States, 2012-2013. | 2013 | 20 |
| 9 | 2013 | 13 | |
| 10 | 2013 | 10 | |
| 11 | 2012 | 15 | |
| 12 | 2011 | 27 | |
| 13 | 2011 | 57 | |
| 14 | 2011 | 38 | |
| 15 | 2010 | 53 | |
| 16 | 2010 | 9 | |
| 17 | 2009 | 108 | |
| 18 | Normal chest radiography in pulmonary tuberculosis: implications for obtaining respiratory specimen cultures. | 2008 | 64 |
| 19 | 2007 | 15 | |
| 20 | 2007 | 20 |
About Jon Warkentin
Jon Warkentin is a scholar working on Infectious Diseases, Epidemiology, Surgery, Pharmacology and Oncology, having authored 22 papers that have together received 510 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (21 papers), Pneumocystis jirovecii pneumonia detection and treatment (10 papers), Pneumonia and Respiratory Infections (9 papers), Mycobacterium research and diagnosis (9 papers), Infectious Diseases and Tuberculosis (3 papers), Cancer therapeutics and mechanisms (2 papers), Diagnosis and treatment of tuberculosis (2 papers) and Clostridium difficile and Clostridium perfringens research (2 papers). The work is most often cited by research in Infectious Diseases (408 citations), Epidemiology (335 citations), Molecular Medicine (31 citations), Surgery (197 citations) and Toxicology (8 citations). Jon Warkentin has collaborated with scholars based in United States, Fiji and South Africa. Frequent co-authors include Timothy R. Sterling, Marie R. Griffin, Fernanda Maruri, Amondrea Blackman, Ayumi Shintani, Ed Mitchel, William Schaffner, Timothy F. Jones, Rose Devasia and R. L. Murphree. Their work appears in journals such as The International Journal of Tuberculosis and Lung Disease, Journal of Clinical Microbiology, Emerging infectious diseases, Epidemiology and Infection and BMC Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.